Home/Filings/4/0001493152-20-018819
4//SEC Filing

Lippa Arnold 4

Accession 0001493152-20-018819

CIK 0000849636other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 3:47 PM ET

Size

11.4 KB

Accession

0001493152-20-018819

Insider Transaction Report

Form 4
Period: 2020-09-30
Lippa Arnold
DirectorChairman, CEO and PresidentOther
Transactions
  • Gift

    Series H Preferred Stock

    2020-09-301000 total
    Exercise: $0.01From: 2020-09-30Exp: 2023-09-30Conversion Units (15,625,000 underlying)
  • Other

    Series H Preferred Stock

    2020-09-30+100100 total
    Exercise: $0.01From: 2020-09-30Exp: 2023-09-30Conversion Units (15,625,000 underlying)
  • Gift

    Series H Preferred Stock

    2020-09-30+1000 total(indirect: By Trust)
    Exercise: $0.01From: 2020-09-30Exp: 2023-09-30Conversion Units (15,625,000 underlying)
Footnotes (5)
  • [F1]The full designation of this class of preferred stock is "Series H 2% Voting, Non-Participating, Convertible Preferred Stock".
  • [F2]On September 30, 2020, Dr. Lippa agreed to forgive a portion of accrued compensation owing from RespireRx Pharmaceuticals Inc. (the "Company") equal to $100,000, and in exchange, the Company issued to Dr. Lippa 100 shares of the Company's Series H 2% Voting, Non-Participating, Convertible Preferred Stock, which equates to a per share value of $1,000.00 per share.
  • [F3]Each Conversion Unit consists of one share of the common stock of the Company, and one warrant exercisable into one share of the common stock of the Company (such warrant having an initial exercise price of $0.007 per share, and terminating on September 30, 2023).
  • [F4]The disposition or acquisition, as applicable, reflects an estate planning transaction.
  • [F5]Dr. Lippa gifted these securities into a family trust for the benefit of his spouse, daughter and grandchildren. Dr. Lippa is not the trustee, does not exercise voting or investment control over shares held in the trust, and disclaims beneficial ownership of the shares of Series H Preferred Stock owned by the trust, except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

RespireRx Pharmaceuticals Inc.

CIK 0000849636

Entity typeother

Related Parties

1
  • filerCIK 0001363763

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 3:47 PM ET
Size
11.4 KB